Licensee’s Continuing Obligations. Nothing in Section 2.5 may be construed to relieve Licensee of its obligations to DFCI under this Agreement, including but not limited to Licensee’s obligations under Article 9.
Appears in 3 contracts
Samples: Exclusive License Agreement, Exclusive License Agreement (Viela Bio, Inc.), Exclusive License Agreement (Aveo Pharmaceuticals Inc)
Licensee’s Continuing Obligations. Nothing in this Section 2.5 may be construed to relieve Licensee of its obligations to DFCI under this Agreement, including but not limited to Licensee’s obligations under Article 9ARTICLE IX.
Appears in 2 contracts
Samples: License Agreement (Fate Therapeutics Inc), Non Exclusive License Agreement (X4 Pharmaceuticals, Inc)
Licensee’s Continuing Obligations. Nothing in Section 2.5 may be construed to relieve Licensee of its obligations to DFCI under this Agreement, including but not limited to Licensee’s obligations under Article 9.. Agreement no. 3899
Appears in 1 contract
Samples: License Agreement (Transgenomic Inc)
Licensee’s Continuing Obligations. Nothing in this Section 2.5 2.7 (Sublicensing) may be construed to relieve Licensee LICENSEE of its obligations to DFCI under this Agreement, including but not limited to LicenseeLICENSEE’s obligations under Article 99 - Indemnification, Defense, and Insurance.
Appears in 1 contract
Samples: License Agreement (Fibrogen Inc)
